BPO 0.00% 0.3¢ bioprospect limited

gearing up to the next level, page-13

  1. 34 Posts.
    I think your brother would look at me the same way.
    I'm certainly not a patent attorney but from my understanding it would not be possible to 'extend' the life of the old Heartlink patents. Also I believe that to have any chance of gaining a new patent the method described would have to be sufficiently novel and unpublished. I'm guessing that would take quite some time & a lot of $ to research/develop.

 
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.